Company Filing History:
Years Active: 2023
Title: **Evans Monyoncho: Innovator in Pharmaceutical Sciences**
Introduction
Evans Monyoncho, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of pharmacology. With a keen focus on somatostatin modulators, he holds a patent that enhances our understanding and treatment options for various diseases.
Latest Patents
Monyoncho's sole patent pertains to the crystalline forms of a somatostatin modulator, specifically 4-[(3S)-3-aminopyrrolidin-1-yl]-6-cyano-5-(3,5-difluorophenyl)-N-[(2S)-1,1,1-trifluoropropan-2-yl]pyridine-3-carboxamide. This innovative work details the uses of such crystalline forms in the preparation of pharmaceutical compositions aimed at treating ailments that could benefit from somatostatin modulation.
Career Highlights
Currently, Monyoncho is making strides at Crinetics Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical development. His work is pivotal for advancing therapeutic options in the medical field.
Collaborations
During his career, Monyoncho has collaborated with esteemed colleagues, including Yuxin Zhao and Jayachandra P Reddy. These partnerships enhance the creative and innovative processes within the organization, fostering the development of novel therapies.
Conclusion
Evans Monyoncho's work exemplifies the spirit of innovation in the life sciences. With his patent on somatostatin modulators, he is poised to contribute significantly to patient care and treatment methodologies, reinforcing the essential role of inventors in advancing healthcare solutions.